Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signaling

Autor: Graham, Keith 1, 2, Lienau, Philip 1, Bader, Benjamin 1, 2, Prechtl, Stefan 1, 2, Naujoks, Jan 1, 2, Lesche, Ralf 1, 2, Weiske, Joerg 1, 2, Kuehnlenz, Julia 1, Brzezinka, Krzysztof 1, 2, Potze, Lisette 1, Zanconato, Francesca 3, Nicke, Barbara 1, 2, Montebaur, Anna 1, Bone, Wilhelm 1, 2, Golfier, Sven 1, 2, Kaulfuss, Stefan 1, 2, Kopitz, Charlotte 1, 2, Pilari, Sabine 1, Steuber, Holger 1, 2, Hayat, Sikander 1, Kamburov, Atanas 1, Steffen, Andreas 1, Schlicker, Andreas 1, Buchgraber, Philipp 1, Braeuer, Nico 1, 2, Font, Nuria Aiguabella 1, Heinrich, Tobias 1, Kuhnke, Lara 1, Nowak-Reppel, Katrin 1, 2, Stresemann, Carlo 1, 2, Steigemann, Patrick 1, 2, Walter, Annette O. 1, Blotta, Simona 1, Ocker, Matthias 1, Lakner, Ashley 1, von Nussbaum, Franz 1, 2, Mumberg, Dominik 1, Eis, Knut 1, Piccolo, Stefano 3, 4, Lange, Martin 1, 2, 5, ∗
Zdroj: In Cell Chemical Biology 18 July 2024 31(7):1247-1263
Databáze: ScienceDirect